The company develops a spatial biology system designed for high-content de novo spatial proteomics. The company's technology converts high-content microscopes into precision photolabeling machines, enabling the identification of novel proteins and biomarkers by harvesting proteins from specific subcellular locations for basic research and disease diagnostic applications.